| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/03/2008 | WO2008077823A1 Self-microemulsifying drug delivery systems |
| 07/03/2008 | WO2008077712A1 Gel useful for the delivery of ophthalmic drugs |
| 07/03/2008 | WO2008077641A1 Nanoemulsion |
| 07/03/2008 | WO2008077236A1 Adp-ribosyl transferase fusion variant proteins |
| 07/03/2008 | WO2008077234A1 Synergistic effects of c3, cyclic amp and ciliary neurotrophic factor on neuronal survival and axonal regeneration |
| 07/03/2008 | WO2008077201A1 Naphthalan oil-based composition |
| 07/03/2008 | WO2008057442A3 Eyelid scrub composition |
| 07/03/2008 | WO2008051186A3 Nanoemulsion containing compositions having ant i -inflammatory activity |
| 07/03/2008 | WO2008042619A3 Self-preserved aqueous pharmaceutical compositions |
| 07/03/2008 | WO2008036855A3 Self-preserved aqueous pharmaceutical compositions |
| 07/03/2008 | WO2008036838A3 Isolated complexes of covalently cross-linked endotoxin and modified md-2 |
| 07/03/2008 | WO2008028667A3 Use of glycolipids as adjuvants |
| 07/03/2008 | WO2008027944A3 Antigenic protein conjugates and process for preparing same |
| 07/03/2008 | WO2008027854A3 Pharmaceutical compositions comprising hgh for oral delivery |
| 07/03/2008 | WO2008019115A3 Formulations for parenteral delivery of compounds and uses thereof |
| 07/03/2008 | WO2006082530A3 Conjugation of streptococcal capsular saccharides to carrier proteins |
| 07/03/2008 | US20080161908 Apparatus and Method for Delivery of Mitomycin Through an Eluting Biocompatible Implantable Medical Device |
| 07/03/2008 | US20080161907 Stent coated with a sustained-release drug delivery and method for use thereof |
| 07/03/2008 | US20080161539 Recombinant colony stimulating factor, erythropoietin, interferon and/or growth hormone cell stimulating factor (G-CSF) for use in treatment and prevention of viral and cell proliferative disorders |
| 07/03/2008 | US20080161425 Regulation of Tissue Factor Activity by Protein S and Tissue Factor Pathway Inhibitor |
| 07/03/2008 | US20080161420 Detecting and monitoring regression, recurrence, and/or response to treatment diseases associated with genetic abnormalities especially tumors |
| 07/03/2008 | US20080161406 Novel formulations of alpha-2,4-disulfophenyl-N-tert-butylnitrone |
| 07/03/2008 | US20080161392 Based on 3-iodo-2-propynyl butylcarbamate (IPBC), a liquid carrier and a stabilizer; free of benzoic acid, propionic acid, salicylic acid, sorbic acid, 4-hydroxybenzoic acid, dehydroacetic acid and 10-undecylenic acid |
| 07/03/2008 | US20080161376 Using antimycotic formulation containing propylene glycol, disodium edta, mineral oil, polyglyceryl-3-oleate, glyceryl monoisostearate, microcrystalline wax, silicon dioxide, methylparaben, propylparaben, butoconazole nitrate in water and sorbitol solution |
| 07/03/2008 | US20080161364 Enteric Medicinal Composition For Oral Use |
| 07/03/2008 | US20080161357 Devices and methods for pain management |
| 07/03/2008 | US20080161356 Precise, long duration; metered systemic delivery of sufentanil; minimizing tissue trauma; reducing gastrointestinal and respiratory system side effects |
| 07/03/2008 | US20080161335 Oral formulations |
| 07/03/2008 | US20080161334 Macrolides |
| 07/03/2008 | US20080161276 Monoacyl lipid, diacyl glycerol, tocopherol, and fragmentation agent; capable of self-dispersing to provide colloidal non-lamellar particles upon contact with an aqueous fluid; controlled-release formulations and for solubilising relatively insoluble compounds |
| 07/03/2008 | US20080161266 Aqueous solution of alginate having guluronic units bound to an adjacent guluronic unit as a percentage of the total number of monomeric units and a cationic antimicrobial agent; forms less deactivating complexes with cationic antimicrobial agent |
| 07/03/2008 | US20080161250 Topical treatment or prevention of ocular infections |
| 07/03/2008 | US20080161233 Sustained Release Formulation of a Peptide |
| 07/03/2008 | US20080160098 Use of simple amino acids to form porous particles |
| 07/03/2008 | US20080160092 Use of simple amino acids to form porous particles |
| 07/03/2008 | US20080160084 Useful in encapsulating dyes, medications and vitamins; limits the degradation |
| 07/03/2008 | US20080160082 Controlled release compositions comprising Nimesulide |
| 07/03/2008 | US20080160077 bioactive lipophilic molecules, such as Coenzyme Q10 (CoQ10) and its reduced analogs (ubiquinols); increased bioavailability |
| 07/03/2008 | US20080160076 consist of water-insoluble hydrophobic synthetic materials which do not significantly affect the pharmaceutical quality of the contents themselves, but improve usability of filled capsules with regard to function, longevity, and/or the geographic location of their use |
| 07/03/2008 | US20080160074 three-dimensional synthetic and semi-synthetic compositions having biological activity, such as liposomes, beads or similar particles; anti-inflammatory, organ protective and immune regulatory effects |
| 07/03/2008 | US20080160063 particles or coils or stents coated with platelet binding agents are directed to target vasculature, such as the vasculature of solid tumor masses or AV-malformations or aneurysms or endoleaks |
| 07/03/2008 | US20080160062 Medical devices based on modified polyols |
| 07/03/2008 | US20080160047 Oil in water emulsions containing saponins |
| 07/03/2008 | US20080160044 Soy Peptone as a Nitrogen Source in Preparing Meningcoccal Conjugates |
| 07/03/2008 | US20080160017 Cross-Linked Antibodies |
| 07/03/2008 | US20080160012 Using transmembrane protein with EGF-like and 2 follistatin-like domains 2 (TMEFF2) specific immunogllobulin for use in diagnosis, prevention and treatment prostate cancer |
| 07/03/2008 | US20080160007 Diagnosis and treatment of cancer related to human dormancy |
| 07/03/2008 | US20080159984 Compositions Capable of Facilitating Penetration Across a Biological Barrier |
| 07/03/2008 | US20080159970 Forming protective coating including moisturizer agent; imparting smooth, pleasant feel to skin; masking aging and/or skin disorder blemishes |
| 07/03/2008 | US20080159959 antiinflammatory agents has water-soluble N-(2-hydroxypropyl) methacrylamide copolymer linked to a glucocorticoid; drug conjugated with a polymer for targeting to bone or cartilage tissue; treatment of rheumatoid arthritis using MR imaging techniques |
| 07/03/2008 | DE112005000730T5 Ionen bindende Polymere und ihre Verwendung Ion-binding polymers and their use |
| 07/03/2008 | DE102007061970A1 Cosmetic, pharmaceutical or dermatological composition, useful for cosmetic and medical purposes, comprises copolymer, which is obtained through copolymerizing e.g. acrylamidoalkylsulfonic acid, comonomer, cross-linker and care components |
| 07/03/2008 | CA2790018A1 Formulations |
| 07/03/2008 | CA2709428A1 Adp-ribosyl transferase fusion variant proteins |
| 07/03/2008 | CA2684165A1 Oligonucleotide-prolyethylene glycol compound |
| 07/03/2008 | CA2674128A1 Self-microemulsifying drug delivery systems |
| 07/03/2008 | CA2673638A1 Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing |
| 07/03/2008 | CA2673627A1 Ciclesonide containing sterile aqueous suspension |
| 07/03/2008 | CA2673622A1 Lipid |
| 07/03/2008 | CA2673543A1 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 07/03/2008 | CA2671900A1 Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof |
| 07/03/2008 | CA2670715A1 Nanoemulsion comprising aqueous components |
| 07/03/2008 | CA2667072A1 Gel useful for the delivery of ophthalmic drugs |
| 07/02/2008 | EP1939174A1 Inclusion complex of ezetimibe and a cyclodextrin and processes in the preparation thereof |
| 07/02/2008 | EP1938843A1 Lipids and lipid assemblies comrising transfection enhancer elements |
| 07/02/2008 | EP1938842A1 Method for preparation of pharmaceutical composition having improved disintegradability |
| 07/02/2008 | EP1938834A1 Treatment of type 1 diabetes before and after expression of predisposition markers |
| 07/02/2008 | EP1938821A2 Methods of administering epothilone analogs for the treatment of cancer |
| 07/02/2008 | EP1938820A1 Liquid preparation for external application containing indomethacin |
| 07/02/2008 | EP1938809A1 Adhesive skin patch |
| 07/02/2008 | EP1938808A1 Preparation for external use |
| 07/02/2008 | EP1938802A1 Interfering RNAs targeting pro-inflammatory cytokines |
| 07/02/2008 | EP1938801A1 Nanoemulsion |
| 07/02/2008 | EP1938798A1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 07/02/2008 | EP1937851A2 Methods and compositions for generating bioactive assemblies of increased complexity and uses |
| 07/02/2008 | EP1937814A2 Anti-apoptotic protein antibodies |
| 07/02/2008 | EP1937311A2 Methods and compositions for modulating immune tolerance |
| 07/02/2008 | EP1937310A2 Use of conjugates of doxorubicin with lactosaminated albumin |
| 07/02/2008 | EP1937308A1 Synthetic polyvalent carbohydrates as components of microbicides |
| 07/02/2008 | EP1937276A2 Improved testosterone gel and method of use |
| 07/02/2008 | EP1937228A1 Pharmaceutical composition based on a morpholinic antimycotic agent and a water-soluble film-forming agent for ungual and periungual application |
| 07/02/2008 | EP1937224A2 Skincare products |
| 07/02/2008 | EP1937213A1 Systems and methods for manufacturing liposomes |
| 07/02/2008 | EP1937211A2 Surfactant systems for delivery of organic compounds |
| 07/02/2008 | EP1713438B1 Medicinal soap |
| 07/02/2008 | EP1694845A4 Anticarcinoma antibidies and uses thereof |
| 07/02/2008 | EP1680076B1 Pharmaceutical and cosmetic formulations for treating fingernails |
| 07/02/2008 | EP1657263B1 Polymer sustainedly releasing amino acid derivative, cosmetic and fiber construct containing the polymer, method of producing the same and method of regenerating the same |
| 07/02/2008 | EP1592451B1 Stable dispersion of solid particles comprising a water-insoluble pyrazine compound |
| 07/02/2008 | EP1572747B1 Tumor-specific recognition molecules |
| 07/02/2008 | EP1487791B1 A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)- methylethyl pentanoate |
| 07/02/2008 | EP1451181B1 Dimeric compounds and their use as anti-viral agents |
| 07/02/2008 | EP1427436B1 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 07/02/2008 | EP1366455B1 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 07/02/2008 | EP1339749B1 Methods for producing improved dextran-hemoglobin conjugates |
| 07/02/2008 | EP1282404B1 Method for preparing microparticles having a selected polymer molecular weight |
| 07/02/2008 | EP1200091B1 Pharmaceutical composition comprising tadalafil |
| 07/02/2008 | EP1094781B1 Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |
| 07/02/2008 | CN101213208A Mutant of granulocyte-colony stimulating factor(G-CSF) and chemically conjugated polypeptide thereof |
| 07/02/2008 | CN101213207A Method for preparing a covalently cross linked oligomer of amyloid beta peptides |